BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 11383938)

  • 1. Biogenic amine metabolites and thiamine in cerebrospinal fluid in heredo-degenerative ataxias.
    Botez MI; Young SN
    Can J Neurol Sci; 2001 May; 28(2):134-40. PubMed ID: 11383938
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Thiamine status in inherited degenerative ataxias.
    Pedraza OL; Botez MI
    J Neurol Neurosurg Psychiatry; 1992 Feb; 55(2):136-7. PubMed ID: 1538220
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Monoamine metabolites in normal human cerebrospinal fluid and in degenerative diseases of the central nervous system.
    González-Quevedo A; García JC; Fernández R; Fernández Cartaya L
    Bol Estud Med Biol; 1993; 41(1-4):13-9. PubMed ID: 7521168
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Treatment of heredo-degenerative ataxias with amantadine hydrochloride.
    Botez MI; Young SN; Botez T; Pedraza OL
    Can J Neurol Sci; 1991 Aug; 18(3):307-11. PubMed ID: 1913365
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of anticonvulsant treatment and low levels of folate and thiamine on amine metabolites in cerebrospinal fluid.
    Botez MI; Young SN
    Brain; 1991 Feb; 114 ( Pt 1A)():333-48. PubMed ID: 1705463
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cerebrospinal fluid levels of monoamine metabolites in panic disorder.
    Eriksson E; Westberg P; Alling C; Thuresson K; Modigh K
    Psychiatry Res; 1991 Mar; 36(3):243-51. PubMed ID: 1712114
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Age effect on dopamine and serotonin metabolite levels in cerebrospinal fluid.
    Seifert WE; Foxx JL; Butler IJ
    Ann Neurol; 1980 Jul; 8(1):38-42. PubMed ID: 6157351
    [TBL] [Abstract][Full Text] [Related]  

  • 8. 3-methoxy-4-hydroxyphenylglycol, 5-hydroxyindoleacetic acid, and homovanillic acid in human cerebrospinal fluid. Storage and measurement by reversed-phase high-performance liquid chromatography and coulometric detection using 3-methoxy-4-hydroxyphenyllactic acid as an internal standard.
    Javors MA; Bowden CL; Maas JW
    J Chromatogr; 1984 Dec; 336(2):259-69. PubMed ID: 6085084
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cerebrospinal fluid levels of monoamine metabolites. A preliminary study of their relation to menstrual cycle phase, sex steroids, and pituitary hormones in healthy women and in women with premenstrual syndrome.
    Eriksson E; Alling C; Andersch B; Andersson K; Berggren U
    Neuropsychopharmacology; 1994 Nov; 11(3):201-13. PubMed ID: 7532413
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The treatment of spinocerebellar ataxias: facts and hypotheses.
    Botez MI; Botez-Marquard T; Mayer P; Marchand L; Lalonde R; Reader TA
    Med Hypotheses; 1998 Nov; 51(5):381-4. PubMed ID: 9848465
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Monoamine metabolites in the CSF of epileptic patients.
    Laxer KD; Sourkes TL; Fang TY; Young SN; Gauthier SG; Missala K
    Neurology; 1979 Aug; 29(8):1157-61. PubMed ID: 37460
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Study on monoamine metabolite contents of cerebrospinal fluid in patients with neurodegenerative diseases.
    Ichikawa N
    Tohoku J Exp Med; 1986 Dec; 150(4):435-46. PubMed ID: 2436350
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Low lumbar CSF levels of homovanillic acid and 5-hydroxyindoleacetic acid in multiple system atrophy with autonomic failure.
    Polinsky RJ; Brown RT; Burns RS; Harvey-White J; Kopin IJ
    J Neurol Neurosurg Psychiatry; 1988 Jul; 51(7):914-9. PubMed ID: 2462617
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lower CSF homovanillic acid levels in depressed patients with a history of alcoholism.
    Sher L; Oquendo MA; Li S; Huang YY; Grunebaum MF; Burke AK; Malone KM; Mann JJ
    Neuropsychopharmacology; 2003 Sep; 28(9):1712-9. PubMed ID: 12825091
    [TBL] [Abstract][Full Text] [Related]  

  • 15. CSF amine metabolites and depression.
    Peabody CA; Faull KF; King RJ; Whiteford HA; Barchas JD; Berger PA
    Psychiatry Res; 1987 May; 21(1):1-7. PubMed ID: 2440071
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Reproducibility of monoamine metabolite measurements in human cerebrospinal fluid.
    Hildebrand J; Bourgeois F; Buyse M; Przedborski S; Goldman S
    Acta Neurol Scand; 1990 May; 81(5):427-30. PubMed ID: 1695809
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Concentrations of monoamines and monoamine metabolites in cerebrospinal fluid determined by high-performance liquid chromatography with electrochemical detection].
    Yoshino K
    No To Shinkei; 1982 Nov; 34(11):1099-106. PubMed ID: 6186264
    [TBL] [Abstract][Full Text] [Related]  

  • 18. No major influence of regular tobacco smoking on cerebrospinal fluid monoamine metabolite concentrations in patients with psychotic disorder and healthy individuals.
    Hjärpe J; Söderman E; Andreou D; Sedvall GC; Agartz I; Jönsson EG
    Psychiatry Res; 2018 May; 263():30-34. PubMed ID: 29482043
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Aggression in humans correlates with cerebrospinal fluid amine metabolites.
    Brown GL; Goodwin FK; Ballenger JC; Goyer PF; Major LF
    Psychiatry Res; 1979 Oct; 1(2):131-9. PubMed ID: 95232
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Monoamine metabolites in cerebrospinal fluid during acute cerebral ischemia.
    Tang HZ; Lu XF; Wang KJ; Ou YS; Huang YQ
    Chin Med J (Engl); 1989 Jan; 102(1):18-23. PubMed ID: 2475306
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.